🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsSemaglutide (Ozempic / Wegovy)Long-term semaglutide (3+ years) — member check-in thread Page 4

Long-term semaglutide (3+ years) — member check-in thread

mike_nyc Sat, May 30, 2026 at 10:03 AM 22 replies 376 viewsPage 4 of 5
TrialTracker_MD
Senior Member
2,345
15,678
Jan 2024
Maryland
Jun 3, 2026 at 10:59 AM#16

Clinical perspective, offered as context rather than as advice. Order of operations matters more than any single choice here: establish a baseline, change one thing, wait long enough for it to express itself, then measure again under the same conditions.

14 12Dr.EM_Chicago, pete_RVA, CarlaRPh_TPA and 11 others
Reply Quote Save Share Report
lori_vegas
Member
378
1,678
Aug 2024
Las Vegas, NV
Jun 3, 2026 at 4:06 PM#17
Dr.PeteFamMed said:
For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine.

Genuinely useful, thank you. I had the facts and not the framework. Sending this to two other people who asked me the same thing last week.

15 13bbq_ray_KC, oliver_london, tane_welly and 12 others
Reply Quote Save Share Report
BariatricNurseD
Senior Member
1,678
7,234
Feb 2024
Dallas, TX
Online
Jun 3, 2026 at 9:13 PM#18

Adding the clinical framing, because it changes how the question reads. The mechanism and the magnitude are separate questions. Agreeing that something happens says nothing about whether it happens enough to act on.

Last edited: Jun 4, 2026 at 2:13 AM
16 14josh_phd_bmore, roxy_nash, tony_orlando and 13 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides

GL Biochem (Shanghai) Ltd. — Direct Manufacturer

Est. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.

Browse GL Biochem
Dr.RenalNash
VIP Member
1,234
7,890
Mar 2024
Nashville, TN
Jun 4, 2026 at 2:20 AM#19
BariatricNurseD said:
The mechanism and the magnitude are separate questions.

This matches mine closely enough to be worth saying so. The dose-response is real but shallow at the top. Across STEP 1 and STEP 4 the gap between 1.7mg and 2.4mg is a couple of percentage points of body weight on average, and the average is carrying a wide spread — plenty of people at 1.7mg sit above the 2.4mg mean. If a dose is working and tolerable, "working" is the relevant variable, not "maximal".

17 15anders_CPH, Dr.NutriCornell, pam_stl and 14 others
Reply Quote Save Share Report
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
Jun 4, 2026 at 7:27 AM#20

Moderator note: the sourcing question belongs in the vendor section and has been split out. No action needed from anybody.

Last edited: Jun 4, 2026 at 9:27 AM
39 12PurityPaulOR, MaxMetOK, MounjBrad and 36 others
Reply Quote Save Share Report

Similar Threads

STEP 1-5 trials comprehensive summary — efficacy endpoints compiled12 replies
Oral semaglutide 50mg Phase 3 — OASIS program results16 replies
Semaglutide pharmacokinetics — half-life, Tmax, steady state modeling10 replies
Compounded semaglutide stability data — temperature and light sensitivity16 replies
0.25mg → 2.4mg titration: optimal schedule based on clinical data6 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register